NMRA Neumora Therapeutics, Inc.
Nasdaq · SEC CIK 1885522 · EDGAR
- Bought, last 12 months
- $15.00M 3 purchases by 3 insiders
- Sold, last 12 months
- $1.09M 9 sales by 4 insiders
- Filings on record
- 101 since 2023-09-18, latest 2026-08-21 19:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ARCH Venture Partners XII, LLC | 10% | $5.00M | — |
| ARCH Venture Partners VIII, LLC | 10% | $5.00M | — |
| Burow Kristina | Dir, 10% | $5.00M | — |
| Aurora Daljit Singh | See Remarks | — | $1.03M |
| BERNS PAUL L | See Remarks, Dir | — | $34.5K |
| Pinto Joshua | Pres | — | $21.1K |
| Milligan Michael Lee | See Remarks | — | $5,127 |
Transactions 73
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-21 19:10 | 2026-08-20+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +88.3K | 69.3K | New | +$63.6K |
| DM | 2026-08-21 19:10 | 2026-08-20+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.53 | -88.3K | 48.8K | -64% | -$135.4K |
| DMI | 2026-08-21 19:10 | 2026-08-20+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +87.8K | 21.1K | New | +$63.2K |
| DMI | 2026-08-21 19:10 | 2026-08-20+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.53 | -87.8K | 0 | -100% | -$134.6K |
| DM | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +122.8K | 79.8K | New | +$88.4K |
| DM | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.55 | -156.9K | 48.8K | -76% | -$242.5K |
| DMI | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | M - OptEx | $0.72 | +120.9K | 30.9K | New | +$87.1K |
| DMI | 2026-08-19 19:17 | 2026-08-17+ | NMRA | Aurora Daljit Singh | See Remarks | S - Sale+OE | $1.56 | -120.9K | 0 | -100% | -$189.2K |
| T | 2026-02-19 | 2026-02-17 | NMRA | Milligan Michael Lee | See Remarks | S - Sale | $3.57 | -1,436 | 21.0K | -6% | -$5,127 |
| 2026-02-19 | 2026-02-17 | NMRA | Pinto Joshua | Pres | S - Sale | $3.54 | -5,967 | 57.8K | -9% | -$21.1K | |
| 2026-02-19 | 2026-02-17 | NMRA | Aurora Daljit Singh | See Remarks | S - Sale | $3.56 | -6,165 | 82.8K | -7% | -$21.9K | |
| 2026-02-19 | 2026-02-17 | NMRA | BERNS PAUL L | See Remarks, Dir | S - Sale | $3.51 | -9,819 | 7.40M | -0.1% | -$34.5K | |
| TI | 2025-11-13 | 2025-11-11 | NMRA | Aurora Daljit Singh | See Remarks | S - Sale | $2.68 | -114.7K | 0 | -100% | -$307.4K |
| I | 2025-10-29 | 2025-10-27 | NMRA | ARCH Venture Partners VIII, LLC | 10% | P - Purchase | $2.61 | +1.92M | 6.05M | +46% | +$5.00M |
| I | 2025-10-29 | 2025-10-27 | NMRA | ARCH Venture Partners XII, LLC | 10% | P - Purchase | $2.61 | +1.92M | 6.05M | +46% | +$5.00M |
| I | 2025-10-29 | 2025-10-27 | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $2.61 | +1.92M | 6.05M | +46% | +$5.00M |
| 2025-05-23 | 2025-05-21 | NMRA | Pinto Joshua | Pres | G - Gift | $0.00 | -13.2K | 63.8K | -17% | $0 | |
| I | 2025-05-23 | 2025-05-21 | NMRA | Pinto Joshua | Pres | G - Gift | $0.00 | +13.2K | 152.2K | +10% | $0 |
| T | 2025-02-20 | 2025-02-18 | NMRA | Lenz Robert A. | Head of R, D | S - Sale | $1.67 | -5,614 | 309.1K | -2% | -$9,375 |
| T | 2025-02-20 | 2025-02-18 | NMRA | Pinto Joshua | Pres | S - Sale | $1.67 | -8,048 | 77.0K | -9% | -$13.4K |
| T | 2025-02-20 | 2025-02-18 | NMRA | BERNS PAUL L | See Remarks, Dir | S - Sale | $1.69 | -13.9K | 7.41M | -0.2% | -$23.4K |
| T | 2025-02-20 | 2025-02-18 | NMRA | Aurora Daljit Singh | Chief Strategy Off | S - Sale | $1.68 | -8,565 | 88.9K | -9% | -$14.4K |
| T | 2025-02-20 | 2025-02-18 | NMRA | Milligan Michael Lee | See Remarks | S - Sale | $1.69 | -1,978 | 22.5K | -8% | -$3,343 |
| M | 2024-12-27 | 2024-12-27 | NMRA | BERNS PAUL L | Dir | G - Gift | $0.00 | -399.3K | 7.55M | -5% | $0 |
| DMT | 2024-10-18 | 2024-10-17+ | NMRA | Fust Matthew K | Dir | M - OptEx | $5.83 | +21.8K | 34.1K | +176% | +$127.0K |
| DMT | 2024-10-18 | 2024-10-17+ | NMRA | Fust Matthew K | Dir | S - Sale+OE | $17.02 | -21.8K | 20.1K | -52% | -$370.9K |
| MT | 2024-10-11 | 2024-10-09+ | NMRA | Lenz Robert A. | Head of R, D | S - Sale | $15.06 | -13.8K | 314.7K | -4% | -$208.1K |
| MT | 2024-09-19 | 2024-09-17+ | NMRA | Lenz Robert A. | Head of R, D | S - Sale | $11.88 | -41.5K | 339.2K | -11% | -$492.7K |
| T | 2024-09-16 | 2024-09-12 | NMRA | Lenz Robert A. | Head of R, D | S - Sale | $11.43 | -32.9K | 370.0K | -8% | -$376.6K |
| TI | 2024-08-27 | 2024-08-27 | NMRA | Pinto Joshua | CFO | S - Sale | $11.39 | -15.7K | 139.0K | -10% | -$178.7K |
| MTI | 2024-08-26 | 2024-08-22+ | NMRA | Pinto Joshua | CFO | S - Sale | $11.67 | -84.3K | 186.3K | -31% | -$984.3K |
| I | 2024-06-28 | 2024-04-17 | NMRA | Pinto Joshua | CFO | G - Gift | $0.00 | -239.0K | 239.0K | -50% | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Fust Matthew K | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Burow Kristina | Dir, 10% | A - Grant | $0.00 | +20.1K | 47.7K | +73% | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Piacquad David | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Halawa Alaa | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Ho Maykin | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| 2024-04-24 | 2024-04-22 | NMRA | Aurora Daljit Singh | Chief Strategy Off | G - Gift | $0.00 | -114.7K | 97.5K | -54% | $0 | |
| D | 2024-02-16 | 2024-02-14 | NMRA | Suh Carol Y. | COO | A - Grant | $0.00 | +85.0K | 374.7K | +29% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | Pinto Joshua | CFO | A - Grant | $0.00 | +85.0K | 324.0K | +36% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | Lenz Robert A. | Head of R, D | A - Grant | $0.00 | +50.0K | 402.9K | +14% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | Aurora Daljit Singh | Chief Strategy Off | A - Grant | $0.00 | +97.5K | 212.2K | +85% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | Gosebruch Henry O | Pres, CEO, Dir | A - Grant | $0.00 | +80.0K | 462.3K | +21% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | BERNS PAUL L | Dir | A - Grant | $0.00 | +171.2K | 7.82M | +2% | $0 |
| D | 2024-02-16 | 2024-02-14 | NMRA | Milligan Michael Lee | See Remarks | A - Grant | $0.00 | +20.6K | 24.4K | +539% | $0 |
| MI | 2023-12-12 | 2023-12-08 | NMRA | ARCH Venture Partners X, L.P. | 10% | J - Other | — | +1.88M | 2.32M | +425% | — |
| MI | 2023-12-12 | 2023-12-08 | NMRA | ARCH Venture Partners XII, LLC | 10% | J - Other | — | +1.88M | 2.32M | +425% | — |
| MI | 2023-12-12 | 2023-12-08 | NMRA | Burow Kristina | Dir, 10% | J - Other | — | +1.88M | 4.13M | +83% | — |
| 2023-12-12 | 2023-12-08 | NMRA | Burow Kristina | Dir, 10% | J - Other | — | +14.0K | 27.6K | +103% | — | |
| MI | 2023-11-15 | 2023-11-13+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $11.77 | +35.0K | 4.13M | +0.9% | +$412.1K |
| MI | 2023-11-15 | 2023-11-13+ | NMRA | ARCH Venture Fund XII, L.P. | 10% | P - Purchase | $11.77 | +35.0K | 4.13M | +0.9% | +$412.1K |
| MI | 2023-11-13 | 2023-11-08+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $10.98 | +140.6K | 4.02M | +4% | +$1.54M |
| MI | 2023-11-13 | 2023-11-08+ | NMRA | ARCH Venture Fund XII, L.P. | 10% | P - Purchase | $10.98 | +140.6K | 4.10M | +4% | +$1.54M |
| MI | 2023-11-07 | 2023-11-03+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $11.49 | +95.7K | 3.93M | +2% | +$1.10M |
| MI | 2023-11-07 | 2023-11-03+ | NMRA | ARCH Venture Partners XII, LLC | 10% | P - Purchase | $11.49 | +95.7K | 3.88M | +3% | +$1.10M |
| MI | 2023-09-29 | 2023-09-28+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $13.68 | +76.5K | 3.80M | +2% | +$1.05M |
| MI | 2023-09-29 | 2023-09-28+ | NMRA | NELSEN ROBERT | 10% | P - Purchase | $13.68 | +76.5K | 3.83M | +2% | +$1.05M |
| MI | 2023-09-27 | 2023-09-26+ | NMRA | NELSEN ROBERT | 10% | P - Purchase | $11.97 | +58.5K | 3.78M | +2% | +$700.5K |
| MI | 2023-09-27 | 2023-09-26+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $11.97 | +58.5K | 3.76M | +2% | +$700.5K |
| MI | 2023-09-25 | 2023-09-22+ | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $11.19 | +100.7K | 3.72M | +3% | +$1.13M |
| MI | 2023-09-25 | 2023-09-22+ | NMRA | NELSEN ROBERT | 10% | P - Purchase | $11.19 | +100.7K | 3.66M | +3% | +$1.13M |
| DMI | 2023-09-21 | 2023-09-19 | NMRA | FMR LLC | See Remark 1 | C - Cnv Deriv | — | +3.71M | 88.3K | New | — |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | NELSEN ROBERT | 10% | C - Cnv Deriv | — | +17.42M | 684.2K | New | — |
| DI | 2023-09-20 | 2023-09-19 | NMRA | NELSEN ROBERT | 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| D | 2023-09-20 | 2023-09-19 | NMRA | Burow Kristina | Dir, 10% | C - Cnv Deriv | — | +13.6K | 13.6K | New | — |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | Burow Kristina | Dir, 10% | C - Cnv Deriv | — | +17.42M | 2.12M | New | — |
| DI | 2023-09-20 | 2023-09-19 | NMRA | Burow Kristina | Dir, 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| DI | 2023-09-20 | 2023-09-19 | NMRA | ARCH Venture Partners VIII, LLC | 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | ARCH Venture Partners VIII, LLC | 10% | C - Cnv Deriv | — | +17.42M | 684.2K | New | — |
| I | 2023-09-19 | 2023-09-19 | NMRA | Gosebruch Henry O | Pres, CEO, Dir | P - Purchase | $12.62 | +15.0K | 15.0K | New | +$189.3K |
| D | 2023-09-19 | 2023-09-19 | NMRA | AMGEN INC | 10% | C - Cnv Deriv | — | +33.60M | 33.60M | New | — |
| D | 2023-09-19 | 2023-09-19 | NMRA | AMGEN INC | 10% | P - Purchase | $17.00 | +1.76M | 35.37M | +5% | +$30.00M |
| D | 2023-09-18 | 2023-09-14 | NMRA | Lenz Robert A. | Head of R, D | A - Grant | $0.00 | +352.9K | 352.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations